Global Cannabinoids Market Size and Forecast 2024-2033|The Supreme Cannabis Company Inc., Elixinol Global Limited, GW Pharmaceuticals PLC., Tilray Inc., Aurora Cannabis Inc

The Cannabinoids Global Market Report 2024 by The Business Research Company provides market overview across 60+ geographies in the seven regions – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, encompassing 27 major global industries. The report presents a comprehensive analysis over a ten-year historic period (2010-2021) and extends its insights into a ten-year forecast period (2023-2033).

Learn More On The Cannabinoids Market:

https://www.thebusinessresearchcompany.com/report/cannabinoids-global-market-report

According to The Business Research Company’s Cannabinoids Global Market Report 2024, The cannabinoids market size has grown exponentially in recent years. It will grow from $33.1 billion in 2023 to $39.86 billion in 2024 at a compound annual growth rate (CAGR) of 20.4%.  The  growth in the historic period can be attributed to medical cannabis legalization, increasing acceptance of cannabis, research and development, regulatory changes, growing awareness of cannabinoid benefits, investments in cannabis industry, consumer trends toward natural products.

The cannabinoids market size is expected to see exponential growth in the next few years. It will grow to $84.38 billion in 2028 at a compound annual growth rate (CAGR) of 20.6%.  The growth in the forecast period can be attributed to wider legalization and decriminalization, research advancements, diverse product offerings, international market expansion, public health awareness initiatives.. Major trends in the forecast period include increasing acceptance and destigmatization, diversification of product offerings, innovation in delivery methods, quality and safety standards, social equity and inclusivity initiatives.

The rising prevalence of chronic diseases is expected to propel the cannabinoid market. Chronic diseases refer to illnesses that last a year or longer and require ongoing medical attention. The effectiveness of cannabinoids, such as smoked marijuana, oromucosal extracts of cannabis-based medication, nabilone, dronabinol, and a new THC analogue, in the treatment of chronic noncancer pain, was examined in a systematic review of randomized controlled trials. For instance, according to the McKinsey report, it is anticipated that the US illness burden will rise by almost 20% through 2040. Furthermore, according to the Center for Disease Control and Prevention, six in ten Americans live with at least one chronic disease. As a result, the rising prevalence of chronic diseases is driving the growth of the cannabinoid market.

Get A Free Sample Of The Report (Includes Graphs And Tables):

https://www.thebusinessresearchcompany.com/sample.aspx?id=8079&type=smp

The cannabinoids market covered in this report is segmented –

1) By Product Type: Cannabidiol, Tetrahydrocannabinol, Cannabinol, Other Product Types

2) By Distribution: Hospital Pharmacies, Retail Pharmacies, Online Stores

3) By Application: Medical, Recreational, Industrial Hemp

Major companies operating in the cannabinoids market are focused on introducing advanced cannabis-based cosmetic solutions, such as CBG and CBD rescue cream, to gain a competitive edge in the market. Cannabis-based cosmetic solutions are cosmetic products that contain cannabis or its derivatives, such as CBD or CBG, as an active ingredient. These products are used in the cosmetic industry for various purposes, such as skin moisturizing, anti-aging, and anti-inflammatory effects. For instance, in November 2022, British Cannabis, a UK-based producer of cannabis, launched the Synergy CBG and CBD Rescue Cream. It is the UK’s first cannabis cosmetic to undertake clinical trials, and it is now all the better from having an extra-active ingredient, CBG, in its formula. Together with two natural, legal cannabis plant extracts, cannabidiol (CBD) and cannabigerol (CBG), Synergy CBD Rescue Cream is a gentle, natural cream that makes up one of the most comprehensive skin care products on the market.

The cannabinoids market report table of contents includes:

1. Executive Summary

2. Cannabinoids Market Characteristics

3. Cannabinoids Market Trends And Strategies

4. Cannabinoids Market – Macro Economic Scenario

5. Global Cannabinoids Market Size and Growth

.

.

.

26. South America Cannabinoids Market

27. Brazil Cannabinoids Market

28. Middle East Cannabinoids Market

29. Africa Cannabinoids Market

30. Cannabinoids Market Competitive Landscape And Company Profiles

Top Major Players:

  • The Supreme Cannabis Company Inc
  • Elixinol Global Limited
  • GW Pharmaceuticals PLC
  • Tilray Inc
  • Aurora Cannabis Inc

Contact Us:

The Business Research Company

Europe: +44 207 1930 708

Asia: +91 88972 63534

Americas: +1 315 623 0293

Email: [email protected]

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Twitter: https://twitter.com/tbrc_info

Facebook: https://www.facebook.com/TheBusinessResearchCompany

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Blog: https://blog.tbrc.info/

Healthcare Blog: https://healthcareresearchreports.com/

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model